Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
about
Parenteral anticoagulation in ambulatory patients with cancerPrimary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgeryTreatment for superficial infusion thrombophlebitis of the upper extremityCanadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.Key points to optimizing management and research on cancer-associated thrombosis.Effect of Huisheng oral solution on coagulation function in perioperative period in patients with primary lung cancer.The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study.Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis.Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.
P2860
Q22252972-D40F0484-E05E-4AE4-B837-318CB9D7D0B8Q24187077-E441968D-2B55-45DF-989D-4E0C7DD9D308Q24187714-887D470A-A830-45A8-801F-803FE775D24CQ33422297-8375A1E9-6D2E-45A0-BB82-B99A5C188B51Q34546366-A1C06931-4A89-4976-B2ED-12D56016C950Q37331210-BE5DA2FE-692C-4C4C-821A-18DA8F95455FQ38865628-836A5D3D-F103-461E-9019-C0495EC79894Q38940637-53AA2115-405C-41FE-BC68-51BE91E5A6BEQ39358771-A9CB1CDC-F628-45EE-AAFC-AF0F3F507C58Q41241927-7348E87E-EF5D-4CF3-B991-86212A37A42AQ41691664-3CE714FE-BE2C-44E0-9AD5-B66CDAB9B032Q47616727-00996A14-9A39-4026-9D8D-5B7A1ABDDE45Q50174496-8C19FF76-2F1B-4B9D-B7B6-F7BAFF113DC0Q50619669-8CEC16C8-1FEE-4792-A051-ED88B8FF31A2Q52339910-9A85E3BC-6A68-4E67-A768-06E591C7FBE6Q55364590-5F76D61B-E477-4A0C-870D-F8DE3444468F
P2860
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Primary prophylaxis for venous ...... atients receiving chemotherapy
@ast
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en-gb
Primary prophylaxis for venous ...... atients receiving chemotherapy
@nl
type
label
Primary prophylaxis for venous ...... atients receiving chemotherapy
@ast
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en-gb
Primary prophylaxis for venous ...... atients receiving chemotherapy
@nl
prefLabel
Primary prophylaxis for venous ...... atients receiving chemotherapy
@ast
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en-gb
Primary prophylaxis for venous ...... atients receiving chemotherapy
@nl
P2860
P1476
Primary prophylaxis for venous ...... atients receiving chemotherapy
@en
P2093
Anne WS Rutjes
Hans-Martin Otten
P2860
P356
10.1002/14651858.CD008500.PUB3
P577
2014-08-29T00:00:00Z